Cargando…
Pathological consequences of MICU1 mutations on mitochondrial calcium signalling and bioenergetics()
Loss of function mutations of the protein MICU1, a regulator of mitochondrial Ca(2 +) uptake, cause a neuronal and muscular disorder characterised by impaired cognition, muscle weakness and an extrapyramidal motor disorder. We have shown previously that MICU1 mutations cause increased resting mitoch...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Pub. Co
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5424885/ https://www.ncbi.nlm.nih.gov/pubmed/28132899 http://dx.doi.org/10.1016/j.bbamcr.2017.01.015 |
_version_ | 1783235208201371648 |
---|---|
author | Bhosale, Gauri Sharpe, Jenny A. Koh, Amanda Kouli, Antonina Szabadkai, Gyorgy Duchen, Michael R. |
author_facet | Bhosale, Gauri Sharpe, Jenny A. Koh, Amanda Kouli, Antonina Szabadkai, Gyorgy Duchen, Michael R. |
author_sort | Bhosale, Gauri |
collection | PubMed |
description | Loss of function mutations of the protein MICU1, a regulator of mitochondrial Ca(2 +) uptake, cause a neuronal and muscular disorder characterised by impaired cognition, muscle weakness and an extrapyramidal motor disorder. We have shown previously that MICU1 mutations cause increased resting mitochondrial Ca(2+) concentration ([Ca(2 +)](m)). We now explore the functional consequences of MICU1 mutations in patient derived fibroblasts in order to clarify the underlying pathophysiology of this disorder. We propose that deregulation of mitochondrial Ca(2+) uptake through loss of MICU1 raises resting [Ca(2+)](m), initiating a futile Ca(2+) cycle, whereby continuous mitochondrial Ca(2+) influx is balanced by Ca(2+) efflux through the sodium calcium exchanger (NLCX(m)). Thus, inhibition of NCLX(m) by CGP-37157 caused rapid mitochondrial Ca(2+) accumulation in patient but not control cells. We suggest that increased NCLX activity will increase sodium/proton exchange, potentially undermining oxidative phosphorylation, although this is balanced by dephosphorylation and activation of pyruvate dehydrogenase (PDH) in response to the increased [Ca(2+)](m). Consistent with this model, while ATP content in patient derived or control fibroblasts was not different, ATP increased significantly in response to CGP-37157 in the patient but not the control cells. In addition, EMRE expression levels were altered in MICU1 patient cells compared to the controls. The MICU1 mutations were associated with mitochondrial fragmentation which we show is related to altered DRP1 phosphorylation. Thus, MICU1 serves as a signal–noise discriminator in mitochondrial calcium signalling, limiting the energetic costs of mitochondrial Ca(2+) signalling which may undermine oxidative phosphorylation, especially in tissues with highly dynamic energetic demands. This article is part of a Special Issue entitled: ECS Meeting edited by Claus Heizmann, Joachim Krebs and Jacques Haiech. |
format | Online Article Text |
id | pubmed-5424885 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Elsevier Pub. Co |
record_format | MEDLINE/PubMed |
spelling | pubmed-54248852017-06-01 Pathological consequences of MICU1 mutations on mitochondrial calcium signalling and bioenergetics() Bhosale, Gauri Sharpe, Jenny A. Koh, Amanda Kouli, Antonina Szabadkai, Gyorgy Duchen, Michael R. Biochim Biophys Acta Article Loss of function mutations of the protein MICU1, a regulator of mitochondrial Ca(2 +) uptake, cause a neuronal and muscular disorder characterised by impaired cognition, muscle weakness and an extrapyramidal motor disorder. We have shown previously that MICU1 mutations cause increased resting mitochondrial Ca(2+) concentration ([Ca(2 +)](m)). We now explore the functional consequences of MICU1 mutations in patient derived fibroblasts in order to clarify the underlying pathophysiology of this disorder. We propose that deregulation of mitochondrial Ca(2+) uptake through loss of MICU1 raises resting [Ca(2+)](m), initiating a futile Ca(2+) cycle, whereby continuous mitochondrial Ca(2+) influx is balanced by Ca(2+) efflux through the sodium calcium exchanger (NLCX(m)). Thus, inhibition of NCLX(m) by CGP-37157 caused rapid mitochondrial Ca(2+) accumulation in patient but not control cells. We suggest that increased NCLX activity will increase sodium/proton exchange, potentially undermining oxidative phosphorylation, although this is balanced by dephosphorylation and activation of pyruvate dehydrogenase (PDH) in response to the increased [Ca(2+)](m). Consistent with this model, while ATP content in patient derived or control fibroblasts was not different, ATP increased significantly in response to CGP-37157 in the patient but not the control cells. In addition, EMRE expression levels were altered in MICU1 patient cells compared to the controls. The MICU1 mutations were associated with mitochondrial fragmentation which we show is related to altered DRP1 phosphorylation. Thus, MICU1 serves as a signal–noise discriminator in mitochondrial calcium signalling, limiting the energetic costs of mitochondrial Ca(2+) signalling which may undermine oxidative phosphorylation, especially in tissues with highly dynamic energetic demands. This article is part of a Special Issue entitled: ECS Meeting edited by Claus Heizmann, Joachim Krebs and Jacques Haiech. Elsevier Pub. Co 2017-06 /pmc/articles/PMC5424885/ /pubmed/28132899 http://dx.doi.org/10.1016/j.bbamcr.2017.01.015 Text en © 2017 The Authors http://creativecommons.org/licenses/by/4.0/ This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Bhosale, Gauri Sharpe, Jenny A. Koh, Amanda Kouli, Antonina Szabadkai, Gyorgy Duchen, Michael R. Pathological consequences of MICU1 mutations on mitochondrial calcium signalling and bioenergetics() |
title | Pathological consequences of MICU1 mutations on mitochondrial calcium signalling and bioenergetics() |
title_full | Pathological consequences of MICU1 mutations on mitochondrial calcium signalling and bioenergetics() |
title_fullStr | Pathological consequences of MICU1 mutations on mitochondrial calcium signalling and bioenergetics() |
title_full_unstemmed | Pathological consequences of MICU1 mutations on mitochondrial calcium signalling and bioenergetics() |
title_short | Pathological consequences of MICU1 mutations on mitochondrial calcium signalling and bioenergetics() |
title_sort | pathological consequences of micu1 mutations on mitochondrial calcium signalling and bioenergetics() |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5424885/ https://www.ncbi.nlm.nih.gov/pubmed/28132899 http://dx.doi.org/10.1016/j.bbamcr.2017.01.015 |
work_keys_str_mv | AT bhosalegauri pathologicalconsequencesofmicu1mutationsonmitochondrialcalciumsignallingandbioenergetics AT sharpejennya pathologicalconsequencesofmicu1mutationsonmitochondrialcalciumsignallingandbioenergetics AT kohamanda pathologicalconsequencesofmicu1mutationsonmitochondrialcalciumsignallingandbioenergetics AT kouliantonina pathologicalconsequencesofmicu1mutationsonmitochondrialcalciumsignallingandbioenergetics AT szabadkaigyorgy pathologicalconsequencesofmicu1mutationsonmitochondrialcalciumsignallingandbioenergetics AT duchenmichaelr pathologicalconsequencesofmicu1mutationsonmitochondrialcalciumsignallingandbioenergetics |